Hämorrhagische Diathese bei chronischer Urämie

• Literatur

• 1 Rabiner S. F.: Uremic bleeding. In: Progress in Hemostasis and Thrombosis. Spaet T.H. (Ed.) Grüne & Stratton; New York: 1972: 233.
• 2 Remuzzi G, Schieppati A, Mecca G. Abnormal platelet function in haemodialy-sed patients: current concepts. Int. J. Artif. Org. 2: 109-112 1979;
• 3 Castaldi P.A, Rosenberg M.C, Stewart J.H. The bleeding disorder of uremia: a qualitative platelet defect. Lancet II: 66-69 1966;
• 4 Rabiner S.E, Molinas F. The role of phenol and phenolic acid on the thrombocy-topathy and defective platelet aggregation of patients with renal failure. Amer. J. Med. 49: 346-351 1970;
• 5 Lindsay R.M, Friesen M, Koens F, Linton A.L, Oreopoulos D, De Veber G. Platelet function in patients on long term peritoneal dialysis. Clin. Nephrol. 6: 335-339 1976;
• 6 Horowitz H.L, Stein I.M, Cohen B.D, White J.G. Further studies on the platelet inhibiting effect of guanidinosuccinic acid and its role in uremic bleeding. Amer. J. Med. 49: 336 1970;
• 7 Eknoyan G, Wacksman S.J, Glueck H.J, Will J.J. Platelet function in renal failure. New Engl. J. Med. 280: 677-681 1969;
• 8 Salzman E.W, Neri L.L. Adhesiveness of blood platelets in uremia. Thromb. Diath. Haemorrh. 75: 89-92 1966;
• 9 Rabiner S.F, Hrodek O. Platelet factor 3 in normal subjects and patients with renal failure. J. Clin. Invest. 47: 901 1968;
• 10 Steiner R.W, Coggins C, Carvalho C.A. Bleeding time in uremia: a useful test to assess clinical bleeding. Amer. J. Haematol. 7: 107-117 1979;
• 11 Horowitz H.I. Uremic toxins and platelet function. Archs. Intern. Med. 126: 823-826 1970;
• 12 Remuzzi G, Livio M, Marchiaro G, Mecca G, de Gaetano G. Bleeding in renal failure. Altered platelet function in chronic uremia only partly corrected by haemodia-lysis. Nephron 22: 347-353 1978;
• 13 Sakariassen K.S, Bolhuis P.A, Sixma J.J. Human blood platelet adhesion to artery subendothelium is mediated by factor VHI-von Willebrand factor bound to the subendothelium. Nature 279: 636-638 1979;
• 14 Born G.V.R, Bergquist D, Arfors K.E. Evidence for inhibition of platelet activation in blood by a drug effect on erythrocytes. Nature 259: 233-235 1976;
• 15 Turitto V.T, Weiss H.I. Red blood cells: their dual role in thrombus formation. Science 207: 541-543 1980;
• 16 Livio M, Marchesi D, Remuzzi G, Gotti E, Mecca G, de Gaetano G. Uremie bleeding: role of anemia and beneficial effect of red cell transfusions. Lancet II: 1013-1015 1982;
• 17 Remuzzi G, Bertani T, Mecca G, Donati M.B, de Gaetano G. Factor VlII-related protein on vascular intima of patients with chronic renal failure and prolonged bleeding times. Brit. Med. J. 1: 70-72 1978;
• 18 Herrmann R.P, Marshall L.R, Hurst P.E. Bleeding in renal failure: a possible cause. Brit. Med. J. 1: 1601-1602 1977;
• 19 Ekberg M.R, Nilsson I.M, Linell F. Significance of increased factor VIII in early glomerulonephritis. Ann. Intern. Med. 83: 337-341 1975;
• 20 Kazatchkine M, Sultan Y, Caen J.P, Bariety J. Bleeding in uremia: a possible cause. Brit. Med. J. 2: 612-615 1976;
• 21 Warrell Jr. R.P, Hultin M.B, Coller B.S. Increased factor VIII/von Wille-brand factor antigen and von Willebrand factor activity in renal failure. Amer. J. Med. 66: 226-228 1979;
• 22 Howard H.A, Whitworth J.A, Hendrix L.E, Thomas K.B, Firkin B.G. Abnormal factor VIII in chronic renal failure. Med. J. Aust. 1: 148-151 1979;
• 23 Remuzzi G, Livio M, Roncaglioni M.C, Mecca G, Donati M.B, de Gaetano G. Bleeding in renal failure: is von Willebrand factor implicated?. Brit. Med. J. 2: 359-361 1979;
• 24 Warell Jr. R.P, Hultin M.B, Coller B.S. Increased factor VIII/von Wille-brand factor antigen and von Willebrand factor activity in renal failure. Amer. J. Med. 66: 226-228 1979;
• 25 Herrmann R.P, Marshall L.R, Hurst P.E. Bleeding in renal failure: a possible cause. Brit. Med. J. 1: 1601-1602 1977;
• 26 Ruggeri Z.M, Ponticelli C, Mannucci P.M. Factor VIII and chronic renal failure. Brit. Med. J. 1: 1085 1977;
• 27 Deykin D. Uremic bleeding. Kidney Int. 24: 698-705 1983;
• 28 Holmsen H, Day H.J, Setkowsky C.A. Behaviour of adenine nucleotides during the platelet release reaction induced by adenosine diphosphate and adrenalin. Biochem. J. 129: 67-82 1972;
• 29 Karpatkin S, Langer R.M. Biochemical energetic of simulated platelet plug formation. Effect of thrombin, adenine diphosphate and epinephrine on intra- and extracellular adenine nucleotide kinetics. J. Clin. Invest. 47: 2158-2168 1968;
• 30 Holmsen H. The platelet. Its membrane, physiology and biochemistry. Clin. Haematol. 1: 235-266 1972;
• 31 Deykin D. Emerging concepts of platelet function. New Engl. J. Med. 290: 144-145 1974;
• 32 Eknoyan G, Brown C.H. Biochemical abnormalities of platelets in renal failure. Evidence for decreased platelet serotonin, adenosine diphosphate and Mg-dependent adenosine triphosphatase. Amer. J. Nephrol. 1: 17-23 1981;
• 33 Remuzzi G, Benigni A, Dodesini P, Schieppati A, Livio M, Poletti E, Mecca G, de Gaetano G. Parathyroid hormone inhibits human platelet function. Lancet II: 1321-1323 1981;
• 34 Massry S.G, Goldstein D.A. The search for uremic toxin(s) “x”.: PTH. Clin. Nephrol. 11: 181-189 1979;
• 35 Leithner C, Sinzinger H, Kovarik J, Woloszczuk W. Parathyroid hormone does not inhibit platelet aggregation. Lancet I: 367-368 1984;
• 36 Remuzzi G, Benigni A, Dodesini P, Schieppati A, Livio M, de Gaetano G, Day J.S, Smith W.L, Pinca E, Patrignani P, Patrono C. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect. J. Clin. Invest. 71: 762-768 1983;
• 37 Patrono C, Ciabattoni G, Pinea E, Pugliese F, Castrucci G, de Salvo A, Satta M.A, Peskar B.A. Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb. Res. 17: 317-327 1980;
• 38 Moneada S, Gryglewsky R, Bunting S, Vane J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (London) 263: 663-665 1976;
• 39 Leithner C, Winter M, Silberbauer K, Wagner O, Pinggera W, Sinzinger H. Enhanced prostacyclin availability of blood vessels in uraemic humans and rats. In: Dialysis Transplantation Nephrology. Robinson B.H.B, Hawkins J.B. (eds.) Kent; Pitman Medical, Tunbridge Wells: 1978: 418-422.
• 40 Defreyn G, Vergara Dauden M, Machin S.J, Vermylen J. A plasma factor in uraemia which stimulates prostacyclin release from cultured endothelial cells. Thromb. Res. (in Press).
• 41 Janson P.A, Jubelirer S.J, Weinstein M.S, Deykin D. Treatment of bleeding tendency in uremia with cryoprecipitate. New Engl. J. Med. 303: 1318-1322 1980;
• 42 Prowse C.V, Sas G, Gader A.M.A, Cort J.H, Cash J.D. Specificity in the factor VIII response to vasopressin infusion in man. Brit. J. Haematol. 41: 437-447 1979;
• 43 Ludlam C.A, Peake I.R, Allen N, Davies B.L, Furlong R.A, Bloom A.L. Factor VIII and fibrinolytic response to deamino-8-d-arginine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Wille-brand’s disease. Brit. J. Haematol. 45: 499-511 1980;
• 44 Nilsson I.M, Holmberg L, Aberg M, Vilhardt H. The release of plasminogen activator and factor VIII after injection of DDAVP in healthy volunteers and in patients with von Willebrand’s disease. Scand. J. Haematol. 24: 351-359 1980;
• 45 Mannucci P.M, Canciani M.T, Rota L, Donovan B.S. Response of factor VIII/ von Willebrand factor to DDAVP in healthy subjects and patients with haemophilia A and von Willebrand’s disease. Brit. J. Haematol. 47: 283-293 1981;
• 46 Mannucci P.M, Ruggeri Z.M, Pareti F.I, Capitanio A. 1-deamino-8-d-argini-ne vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand’s disease. Lancet I: 869-872 1977;
• 47 Theiss W, Sauer E. DDAVP: Alternative zur Substitutionsbehandlung bei leichter Hämophilie A und Von-Willebrand-Jür-gens-Syndrom. Dtsch. Med. Wschr. 102: 1769-1772 1977;
• 48 Ingram G.I.C, Hilton P.J. DDAVP in haemophilia. Lancet II: 721-722 1977;
• 49 Ockelford P.A, Menon N.C, Berry E.W. Clinical experience with arginine vasopressin (DDAVP) in von Willebrand’s disease and mild haemophilia. N. Z. med. J. 92: 375-378 1980;
• 50 Dewald D.L, Briggs B, Smith R.E. Intranasal administration of desmopressin acetate (DDAVP) to hemophiliacs. Thromb. Res. 18: 617-622 1980;
• 51 Mannucci P.M, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, Zimmermann T.S. Deamino-8-d-arginine vasopressin shortens the bleeding time in uremia. New Engl. J. Med. 308: 8-12 1983;